Clin2
NCT07634484Possibly a fitRecruiting

Pemafibrate for high cholesterol not controlled by statins

Hypercholesterolemia

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests whether pemafibrate, a new medication, can lower cholesterol better when added to statin treatment in patients whose cholesterol remains high despite taking statins regularly. The goal is to see if this combination reduces heart disease risk.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older and have high cholesterol (hypercholesterolemia)
  • You have been taking a statin at a steady dose for at least 4 weeks before screening
  • Your fasting triglycerides (blood fat) are below 150 mg/dL on two separate screening tests
  • Your LDL-C (bad cholesterol) level meets certain thresholds based on your risk category, confirmed on two screening tests
  • You have not had a heart attack, stroke, or major heart surgery in the past 3 months
  • You do not have uncontrolled diabetes, thyroid disease, severe liver disease, gallstones, or severe kidney disease

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07474649Not yet recruiting· Phase 3
Study of a cholesterol-lowering combination pill for patients without heart events

This trial tests a triple therapy pill (bempedoic acid, ezetimibe, and a high-intensity statin) in patients who have extensive plaque in their heart arteries but have never had a heart attack or stroke. It aims to see if this combination can further lower cholesterol and prevent future problems.

Berlin
NCT07562178Recruiting
Pemafibrate to prevent stroke from brain artery narrowing

This trial tests whether a medication called pemafibrate can help prevent future strokes in people who have had a recent stroke or TIA (mini-stroke) caused by a narrowed artery inside the brain. The medication works by lowering triglycerides (a type of fat in the blood).

Toyoake, Aichi-ken
NCT07623915Not yet recruiting· Phase 3
Testing Bempedoic Acid to Lower Cholesterol

This study tests whether bempedoic acid, a new cholesterol-lowering medication, can help people with heart disease or very high cholesterol. You'd take it along with your current cholesterol medications to see if it further reduces your cholesterol levels and protects your heart.

NCT06780410Recruiting· Phase 3
Study of bempedoic acid for lowering cholesterol

This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.

Beijing
NCT07206472Recruiting
Study of bempedoic acid for high cholesterol

This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.

Belo Horizonte
NCT07239414Not yet recruiting· Phase 3
Bempedoic acid vs statins for cholesterol in people who struggle with statins

This trial tests a new medicine called bempedoic acid compared to statins for people who have trouble sticking with statins. It looks at how well each medicine lowers 'bad' cholesterol and how well they are tolerated.

Hear when a new Hypercholesterolemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.